• 1
    Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol. Clin. North Am. 1992; 19: 71323.
  • 2
    Ennis RD, Petrylak DP, Singh P et al. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. J. Urol. 2000; 163: 141318.
  • 3
    Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J. Urol. 1995; 154: 205964.
  • 4
    Bassi P, Ferrante GD, Pizza N et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J. Urol. 1999; 161: 14917.
  • 5
    Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J. Clin. Oncol. 2001; 19: 66675.
  • 6
    Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 2001; 166: 1923.
  • 7
    Dalbagni G, Genega E, Hashibe M et al. Cystectomy for bladder cancer: a contemporary series. J. Urol. 2001; 165: 111116.
  • 8
    Lerner SP, Skinner DG, Lieskowsky G et al. The rationale of en bloc pelvic node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol. 1993; 149: 75864.
  • 9
    Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J. Urol. 2003; 169: 95560.
  • 10
    Jaeger TM, Weidner N, Chew K et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J. Urol. 1995; 154: 6971.
  • 11
    Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod. Pathol. 1996; 9: 10359.
  • 12
    Wishnow KI, Levinson AK, Johnson DE et al. Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy. Urology 1992; 39: 1216.
  • 13
    Bell JT, Burney SW, Friedell GH. Blood vessel invasion in human bladder cancer. J. Urol. 1971; 105: 6758.
  • 14
    Cheng L, Neumann RM, Scherer BG et al. Tumor size predicts the survival of patients with pathological stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999; 85: 263847.
  • 15
    Logothetis CJ, Johnson DE, Chong C et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J. Clin. Oncol. 1988; 6: 15906.
  • 16
    Heney NM, Proppe K, Prout GR, Griffin PP, Shipley WU. Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J. Urol. 1983; 130: 8957.
  • 17
    Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors, 5th edn. Wiley-Liss, New York, 1997.
  • 18
    Mostofi FK, Davis CJ, Sesterhenn IA. Histological Typing of Urinary Bladder Tumours, 2th edn. Springer Verlag, Berlin, 1999.
  • 19
    Fidler IJ. Critical factors in the biology of human cancer metastasis: 28th G.H.A. Clows Memorial Award Lecture. Cancer Res. 1990; 50: 61308.
  • 20
    Honda N, Yamada Y, Mitsui K et al. Clinical study of recurrence in bladder cancer patients undergoing total cystectomy. Acta Urol. Jpn 1999; 45: 31724.
  • 21
    Larsen MP, Steinberg GD, Brendler CB, Epstein JI. Use of Ulex europaeus agglutinin 1 (UEAI) to distinguish vascular and ‘pseudovascular’ invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod. Pathol. 1990; 3: 838.
  • 22
    Murphy WM. ASCP survey on anatomic pathology examination of the urinary bladder. Am. J. Clin. Pathol. 1994; 102: 71519.